Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mignot

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Journal of Sleep Research|June 1, 1997
Circadian distribution of rest/activity in narcoleptic and control dogs: assessment with ambulatory activity monitoringS Nishino, M Tafti, R Sampathkumaran, et al.
Lancet (London, England)|January 1, 2000
Hypocretin (orexin) deficiency in human narcolepsyS Nishino, B Ripley, S Overeem, et al.
The Journal of Clinical Investigation|September 1, 1988
Role of central alpha-1 adrenoceptors in canine narcolepsyE Mignot, C Guilleminault, S Bowersox, et al.
The Journal of Comparative Neurology|March 10, 1997
Mesopontine organization of cholinergic and catecholaminergic cell groups in the normal and narcoleptic dogM Tafti, S Nishino, W Liao, et al.
Sleep|December 1, 1993
Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compoundsS Nishino, J Arrigoni, J Shelton, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|July 4, 2001
Narcolepsy: clinical features, new pathophysiologic insights, and future perspectivesS Overeem, E Mignot, J G van Dijk, et al.
Sleep|February 11, 1998
HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patientsE Mignot, R Hayduk, J Black, et al.
Brain Research|March 15, 1988
Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsyE Mignot, C Guilleminault, S Bowersox, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1995
Effect of 5-HT1A receptor agonists and antagonists on canine cataplexyS Nishino, J Shelton, A Renaud, et al.
European Journal of Pharmacology|November 19, 1991
Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleepA Renaud, S Nishino, W C Dement, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Journal of Sleep Research|June 1, 1997
Circadian distribution of rest/activity in narcoleptic and control dogs: assessment with ambulatory activity monitoringS Nishino, M Tafti, R Sampathkumaran, et al.
Lancet (London, England)|January 1, 2000
Hypocretin (orexin) deficiency in human narcolepsyS Nishino, B Ripley, S Overeem, et al.
The Journal of Clinical Investigation|September 1, 1988
Role of central alpha-1 adrenoceptors in canine narcolepsyE Mignot, C Guilleminault, S Bowersox, et al.
The Journal of Comparative Neurology|March 10, 1997
Mesopontine organization of cholinergic and catecholaminergic cell groups in the normal and narcoleptic dogM Tafti, S Nishino, W Liao, et al.
Sleep|December 1, 1993
Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compoundsS Nishino, J Arrigoni, J Shelton, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|July 4, 2001
Narcolepsy: clinical features, new pathophysiologic insights, and future perspectivesS Overeem, E Mignot, J G van Dijk, et al.
Sleep|February 11, 1998
HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patientsE Mignot, R Hayduk, J Black, et al.
Brain Research|March 15, 1988
Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsyE Mignot, C Guilleminault, S Bowersox, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1995
Effect of 5-HT1A receptor agonists and antagonists on canine cataplexyS Nishino, J Shelton, A Renaud, et al.
European Journal of Pharmacology|November 19, 1991
Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleepA Renaud, S Nishino, W C Dement, et al.
Pageof 17